150 related articles for article (PubMed ID: 33401111)
1. Increased
Fukunaga K; Nagatani Y; Nakagawa H; Nitta-Seko A; Nagata T; Nishizono M; Kobashi K; Iguchi H; Nitta N; Hanaoka J; Murata K; Watanabe Y; Nakano Y
Eur J Radiol; 2021 Feb; 135():109477. PubMed ID: 33401111
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.
Nobashi T; Kubo T; Nakamoto Y; Handa T; Koyasu S; Ishimori T; Mishima M; Togashi K
J Nucl Med; 2016 Dec; 57(12):1899-1904. PubMed ID: 27339874
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of
Akaike K; Saruwatari K; Oda S; Shiraishi S; Takahashi H; Hamada S; Iyama S; Horio Y; Tomita Y; Saeki S; Okamoto S; Ichiyasu H; Fujii K; Sakagami T
Int J Clin Oncol; 2020 Apr; 25(4):681-690. PubMed ID: 31781994
[TBL] [Abstract][Full Text] [Related]
4. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
Peelen DM; Zwezerijnen BGJC; Nossent EJ; Meijboom LJ; Hoekstra OS; Van der Laken CJ; Voskuyl AE
Rheumatology (Oxford); 2020 Jun; 59(6):1407-1415. PubMed ID: 31642912
[TBL] [Abstract][Full Text] [Related]
5. Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.
Maniwa T; Endo M; Isaka M; Nakagawa K; Ohde Y; Okumura T; Kondo H
Surg Today; 2014 Mar; 44(3):494-8. PubMed ID: 24006127
[TBL] [Abstract][Full Text] [Related]
6. (18)FDG uptake associated with CT density on PET/CT in lungs with and without chronic interstitial lung diseases.
Inoue K; Okada K; Taki Y; Goto R; Kinomura S; Fukuda H
Ann Nucl Med; 2009 May; 23(3):277-81. PubMed ID: 19319629
[TBL] [Abstract][Full Text] [Related]
7. Correlation between preoperative
Oishi H; Sakurada A; Notsuda H; Tanaka R; Takanami K; Saito R; Eba S; Noda M; Okada Y
Respir Investig; 2021 Jan; 59(1):106-113. PubMed ID: 33004286
[TBL] [Abstract][Full Text] [Related]
8. The lungs were on fire: a pilot study of
Liang J; Cao H; Liu Y; Ye B; Sun Y; Ke Y; He Y; Xu B; Lin J
Arthritis Res Ther; 2021 Jul; 23(1):198. PubMed ID: 34301306
[TBL] [Abstract][Full Text] [Related]
9. Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.
Flechsig P; Hural O; Kreuter M; Eichhorn M; HEUßEL G; Sachpekidis C; Kauczor HU; Haberkorn U; Heussel CP; Eichinger M
In Vivo; 2018; 32(6):1457-1462. PubMed ID: 30348701
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.
Jahangiri P; Pournazari K; Torigian DA; Werner TJ; Swisher-McClure S; Simone CB; Alavi A
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):206-216. PubMed ID: 30229527
[TBL] [Abstract][Full Text] [Related]
11. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT
Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
13.
Ledoult E; Morelle M; Soussan M; Mékinian A; Béhal H; Sobanski V; Hachulla E; Huglo D; Le Gouellec N; Remy-Jardin M; Baillet C; Launay D
Arthritis Res Ther; 2021 Mar; 23(1):76. PubMed ID: 33673861
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
[TBL] [Abstract][Full Text] [Related]
15. Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting.
Jordon LH; Ganeshan B; Nadeem I; Hoy L; Mahdi N; Porter JC; Groves A; Win T
BMJ Open; 2024 May; 14(5):e081103. PubMed ID: 38816048
[TBL] [Abstract][Full Text] [Related]
16. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
[TBL] [Abstract][Full Text] [Related]
17. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of
Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
[No Abstract] [Full Text] [Related]
19. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
[TBL] [Abstract][Full Text] [Related]
20. Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and
Fraz MSA; Moe N; Revheim ME; Stavrinou ML; Durheim MT; Nordøy I; Macpherson ME; Aukrust P; Jørgensen SF; Aaløkken TM; Fevang B
Front Immunol; 2020; 11():617985. PubMed ID: 33584710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
